title: Hemophagocytic syndrome after highly active antiretroviral therapy initiation: a life-threatening event related to immune restoration inflammatory syndrome?
authors.forename: Melanie
authors.initials: M
authors.lastname: Cuttelod
authors.forename: Andres
authors.initials: A
authors.lastname: Pascual
authors.forename: Audrey S
authors.initials: AS
authors.lastname: Baur Chaubert
authors.forename: Alain
authors.initials: A
authors.lastname: Cometta
authors.forename: Regina
authors.initials: R
authors.lastname: Osih
authors.forename: Michel A
authors.initials: MA
authors.lastname: Duchosal
authors.forename: Matthias
authors.initials: M
authors.lastname: Cavassini
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000139:chemically induced*; D051359:Lymphohistiocytosis, Hemophagocytic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011241:Prednisone